期刊文献+

替加氟对中晚期食管癌放疗增敏效果及副作用观察 被引量:5

THE EFFECT OF TEGAFUR ON SENSITIZATION OF RADIOTHERAPY AND ITS INFLUENCE ON THE SIDE EFFECTS IN PATIENTS WITH MIDLATE STAGE ESOPHAGEAL CARCINOMA
下载PDF
导出
摘要 目的观察口服抗代谢药替加氟在中晚期食管癌放疗中的增敏效果及对放疗副作用的影响。方法将128例初治中晚期食管癌病人随机分为2组,均采用直线加速器6MV-X线进行外照射放疗,靶区剂量为60~64Gy/(6~7)周。实验组自放疗当日口服替加氟,每次0.1~0.2g,每天3次,至放疗结束。对照组在放疗同时伍用顺铂20mg快速静滴,每周2次,按病人对药物的反应及耐受性给予4~6周的增敏。结果两组病人近期疗效差异无显著性,而骨髓抑制和胃肠道不良反应差异有统计学意义(χ2=10.25、3.75,P<0.05)。结论中晚期食管癌放疗并用替加氟增敏效果与顺铂相近,副作用轻微,病人耐受性较好。 Objective To observe the effect of oral tegafur on sensitization of radiotherapy for midlate stage esophageal carcinoma (EC) and its influence on the side effects of radiation. Methods This study enrolled 128 initial treatment patients with midlate stage EC, and were randomized to two groups. They were treated with conventional fraetionated radiotherapy using linear accelerator 6 MV X ray with the target area dosage of 60-64 Gy/(6-7) weeks The patients in the experimental group were given tegafur, 0.1-0.2 g, three times a day, starting from the day of radiation and lasting until completion of radiotherapy; to those in the control group, rapid intravenous drip of cisplatin, 20 rag, twice a week, were given. All the patients received sensitiza tion of 4 6 weeks according to patients' response and tolerance to the drug. Results The difference between the two groups was not significant in terms of short term efficacy, but it was significant in terms of bone marrow depression and adverse reactions of gastrointestinal tract (x^2=10.25,3.75;P〈0.05). Conclusion For patients undergoing radiotherapy for midlate stage EC, the outcome of using tegafur or cisplatin for sensitization is similar, but the side effects of the former is litter, and better tolerated.
出处 《齐鲁医学杂志》 2012年第6期485-486,489,共3页 Medical Journal of Qilu
关键词 食管肿瘤 替加氟 顺铂 辐射增敏药 放射疗法 esophageal neoplasms tegafur cispIatin radiation sensitizing agents radiotherapy
  • 相关文献

参考文献8

  • 1殷蔚伯,余子豪,徐国镇,胡逸民主编..肿瘤放射治疗学 第4版[M].北京:中国协和医科大学出版社,2008:1374.
  • 2韩春 杨香然 等.食管癌后程加速放射治疗前瞻性随机研究[J].中华放射肿瘤学杂志,1999,8:192-192. 被引量:24
  • 3MOSS A A, SCHNYDER P, THOENI R F, et al. Esophage- al carcinoma pretherapy staging by computed tomography[J]. AJR, 1981,136 :1051. 被引量:1
  • 4中华医学会编著..临床诊疗指南 肿瘤分册[M].北京:人民卫生出版社,2005:708.
  • 5王大志,王娟,李德爱,毕晓伟.三种方案在食管癌化疗中的成本效果分析及临床评价[J].齐鲁医学杂志,2008,23(1):8-10. 被引量:5
  • 6董绍安,赵景岚,林乐胜.食管鳞状细胞癌组织MMP-2、9与TIMP-1表达及意义[J].青岛大学医学院学报,2007,43(2):105-107. 被引量:10
  • 7安永恒等主编..肿瘤合理用药[M].北京:人民卫生出版社,2004:904.
  • 8KUBO N, MORIMOTO J, TANAKA H, et al. Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-FU) for locally advanced squamous cell carcinoma of the esophagus[J]. Gan To Kagaku Ryoho, 2009,36(12):1997. 被引量:1

二级参考文献16

  • 1王卫红,陈洪华,马风华.泰素帝治疗恶性肿瘤的护理[J].齐鲁医学杂志,2004,19(4):366-366. 被引量:3
  • 2张采欣,纪祥瑞,张景芳,郝风云.Cathepsin-D、MMP-2和MMP-9在乳癌组织中的表达[J].齐鲁医学杂志,2005,20(3):219-221. 被引量:4
  • 3聂文洁,迟菁华,纪祥瑞,王良忠.星形细胞肿瘤组织MMP-2与TIMP-1、TIMP-2的表达[J].齐鲁医学杂志,2006,21(2):101-102. 被引量:5
  • 4中华人民共和国医政司.常见恶性肿瘤诊治规范[M].北京:中国协和医科大学出版社,1999:773-781. 被引量:10
  • 5OHTANI H,TABATA N,NAGURA,et al.Immunoelectron microscopic localization of gelatinase A in human gastrointestinal and skin carcinomas:difference between cancer cells and fibroblasts[J].Jpn J Cancer Res,1995,86(3):304-309. 被引量:1
  • 6PUFE,HARDE V,DETERSEN W,et al.Vascular endothelial growth factor (VEGF) induces matrix metalloprteinase in immortalized chondrocytes[J].J Pathol,2004,202 (3):367-374. 被引量:1
  • 7GU Z D,CHEN KN,LI M,et al.Clinical significance of matrix metalloproteinase-9 expression in esophageal carcinomas[J].World J Gastroenterol,2005,16(6):871. 被引量:1
  • 8BAKER E A,BERGIN F G,Leaper D J.Matrix metalloproteinases,their tissue inhibitors and colorectal cancer staging[J].Br J Surg,2000,87:1466. 被引量:1
  • 9NUTT J E,MELLON J K,QURESHI K.Matrix metalloprteinase-1 is induced by epidermal growth factor in human bladder tumor cell lines and is detectable in urine of patients with bladder tumors[J].Cancer Res,1998,78(2):215. 被引量:1
  • 10COLLINS H M,MORRIS T M,WATSON S A.Spectrum of matrix metaloproteinas expression in primary and metastatic colon cancer:relationship to the tissue inhibitors of metalloproteinase sand membrane type-1 matrix metalloproteinase[J].Br Cancer,2001,84(12):1664. 被引量:1

共引文献36

同被引文献49

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部